ADIPOQ and breast carcinoma: Similar to the findings regarding the association between the HW phenotype and breast cancer risk, there was a significant difference of total adiponectin in ER+/PR+ (p = 0.028) and ER–/PR– (p = 0.043) breast cancer compared to the controls, who were much lower in the HW phenotype subgroup.